Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer
Background: Immunotherapy with programmed death receptor-1 (PD-1) inhibitors, as a single agent or in combination with chemotherapy, is the standard first-line treatment for recurrent or metastatic head and neck squamous cell cancer (R/M HNSCC). Unfortunately, there is no established second-line tre...
Main Authors: | Kimberly M. Burcher, Chance H. Bloomer, Elena Gavrila, John M. Kalada, Mark J. Chang, Rediet R. Gebeyehu, Alexander H. Song, Lara M. Khoury, Thomas W. Lycan, Rebecca Kinney, Ralph D’Agostino, Paul M. Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M. Furdui, Wei Zhang, Mercedes Porosnicu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359231217959 |
Similar Items
-
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature
by: Chance H. Bloomer, et al.
Published: (2023-08-01) -
A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers
by: Kimberly M. Burcher, et al.
Published: (2022-08-01) -
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
by: Kimberly M. Burcher, et al.
Published: (2021-11-01) -
Serendipitous synergism – an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature
by: Lara M. Khoury, et al.
Published: (2022-10-01) -
Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC
by: Kimberly M. Burcher, et al.
Published: (2021-06-01)